Editorial
Genetic variation and susceptibility to infection
Developments in the therapeutic use of erythropoiesis stimulating agents
Recessive congenital methaemoglobinaemia
Cord blood stem cell transplantation for haemoglobinopathies
The human side of hypoxia-inducible factor
Current status of globin gene therapy for the treatment of β-thalassaemia
Advances in clinical research in sickle cell disease
Genetic modifiers of the β-haemoglobinopathies
Disorders of red cell membrane
Ribosomal dysfunction and inherited marrow failure
Studies in haemoglobin E beta-thalassaemia
A mechanism for Ikaros regulation of human globin gene switching
Is the β thalassaemia trait of clinical importance?